musky , i think we need to see what the FDA's letter asks of us.
maybe their questions will be more related to trial design and implementation of our Trial , which may be questions directed more towards our PI Hidalgo and Iglesius .
I am pleased to see long share holders holding their shares , and not being scared out of their position .
Remember , PMCB did conduct and pass many FDA required tests , and our partner Austrianova submitted our Drug Masterfile to the FDA prior to PMCB IND submission .
Best of Luck